secwatch.observer — SEC 8-K summary
======================================

Issuer:     FRACTYL HEALTH, INC. (GUTS)
CIK:        0001572616
Form:       8-K
Filed at:   2025-09-03T23:59:59+00:00
Accession:  0000950170-25-112671
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Fractyl Health appoints Dr. Christopher Thompson and Ian Sheffield to board; Amy Schulman resigns
--------------------------------------------------------------------------------

- Christopher Thompson, M.D. appointed as Class I director effective Sept 2, 2025.
- Ian Sheffield appointed as Class II director and to audit committee effective Sept 2, 2025.
- Each receives $43,500 annual retainer; Sheffield gets additional $10,000 for audit committee; initial option for 45,000 shares vesting over 3 years.
- Amy W. Schulman resigned as Class I director and from nominating committee effective Sept 2, 2025; no dispute with company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1572616/000095017025112671/0000950170-25-112671-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1572616/000095017025112671/guts-20250829.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-112671

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer